Page last updated: 2024-12-06

doxaminol

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

doxaminol: dibenzoxepine derivative [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID68721
CHEMBL ID2106287
SCHEMBL ID249528
MeSH IDM0105544

Synonyms (14)

Synonym
doxaminolum [inn-latin]
doxaminol [inn]
bm 10188
6,11-dihydro-n-(2-hydroxy-3-phenoxypropyl)-n-methyldibenz(b,e)oxepin-11-ethylamine
2-propanol, 1-((2-(6,11-dihydrodibenz(b,e)oxepin-11-yl)ethyl)methylamino)-3-phenoxy-
doxaminol
55286-56-1
1rz4ml637i ,
doxaminolum
unii-1rz4ml637i
CHEMBL2106287
SCHEMBL249528
Q27252812
DTXSID30866474

Research Excerpts

Pharmacokinetics

ExcerptReferenceRelevance
"The pharmacokinetic behaviour of doxaminol (N-methyl-N-(2-hydroxy-3-phenoxy-propyl)-11-(2-amino-ethyl)-6, 11-dihydrodibenz[b,e]oxepine, neutral fumarate; BM 10."( Pharmacokinetics of the partial beta-agonist doxaminol in dog.
Neidlein, R; Strein, K; Volland, C, 1990
)
0.82
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (7)

TimeframeStudies, This Drug (%)All Drugs %
pre-19904 (57.14)18.7374
1990's3 (42.86)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 70.05

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be very strong demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index70.05 (24.57)
Research Supply Index2.20 (2.92)
Research Growth Index4.40 (4.65)
Search Engine Demand Index173.53 (26.88)
Search Engine Supply Index3.00 (0.95)

This Compound (70.05)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other8 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]